Mesoblast (NASDAQ:MESO) Downgraded to "Hold" Rating by …

Dec 23, 2024 · A number of other analysts also recently issued reports on MESO. Maxim Group raised Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 target price on the …

$12.00
OFF

Mesoblast (NASDAQ:MESO) Downgraded To "Hold" Rating By …

2 weeks from now

Dec 23, 2024 · A number of other analysts also recently issued reports on MESO. Maxim Group raised Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 target price on the …

marketbeat.com

$17.02
OFF

Mesoblast (NASDAQ:MESO) Cut To Hold At Jefferies Financial Group

2 weeks from now

Dec 25, 2024 · Shares of NASDAQ:MESO opened at $17.02 on Monday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.18 and a quick ratio of 1.18. Mesoblast has a …

etfdailynews.com

2%
OFF

Mesoblast (NASDAQ:MESO) Trading Down 2.2% - Here's Why

2 weeks from now

20 hours ago · Piper Sandler raised their price objective on shares of Mesoblast from $11.00 to $15.00 and gave the company an "overweight" rating in a research note on Thursday, …

marketbeat.com

$2.30
OFF

Mesoblast Downgraded To Hold From Buy At Jefferies - Nasdaq

2 weeks from now

Dec 23, 2024 · Jefferies downgraded Mesoblast (MESO) to Hold from Buy with a price target of A$2.30, up from A$1.10. The firm updated the company’s for the FDA’ss recent approval of …

nasdaq.com

4%
OFF

Mesoblast (NASDAQ:MESO) Shares Down 3.4% - MarketBeat

2 weeks from now

Jan 7, 2025 · Jefferies Financial Group lowered Mesoblast from a "buy" rating to a "hold" rating in a research note on Monday, December 23rd. Piper Sandler upped their price target on shares …

marketbeat.com

$12.00
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Time To Sell?

2 weeks from now

1 day ago · MESO has been the topic of a number of recent research reports. Maxim Group raised Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 target price on the …

marketbeat.com

7%
OFF

Mesoblast (NASDAQ:MESO) Stock Price Down 5.7% – Here’s Why

2 weeks from now

Dec 29, 2024 · Shares of Mesoblast Limited (NASDAQ:MESO – Get Free Report) fell 5.7% on Friday . The stock traded as low as $17.16 and last traded at $17.25. 88,059 shares were …

etfdailynews.com

$20.97
OFF

Mesoblast (NASDAQ:MESO) Hits New 12-Month High – Still A Buy?

2 weeks from now

Jan 1, 2025 · Mesoblast Limited (NASDAQ:MESO – Get Free Report)’s share price hit a new 52-week high on Monday . The stock traded as high as $20.97 and last traded at $20.75, with a …

etfdailynews.com

$12.00
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What …

2 weeks from now

Jan 3, 2025 · Maxim Group upgraded Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 target price on the stock in a research report on Tuesday, September 24th. Finally, …

marketbeat.com

FAQs about Mesoblast (NASDAQ:MESO) Downgraded to "Hold" Rating by … Coupon?

Is Mesoblast (meso) a good stock to buy?

Mesoblast (NASDAQ:MESO – Get Free Report) was downgraded by investment analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued on Monday, MarketBeat reports. MESO has been the topic of several other reports. ...

How much does Mesoblast (meso) cost?

Shares of NASDAQ:MESO opened at $17.02 on Monday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.18 and a quick ratio of 1.18. Mesoblast has a 12 month low of $1.61 and a 12 month high of $19.15. The stock’s 50 day moving average price is $10.77 and its 200 day moving average price is $8.44. ...

How do I receive news & ratings for Mesoblast?

Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter. ...

What is Piper Sandler's target price on Mesoblast?

Piper Sandler upped their target price on Mesoblast from $11.00 to $15.00 and gave the stock an “overweight” rating in a research report on Thursday, December 19th. Maxim Group upgraded Mesoblast from a “hold” rating to a “buy” rating and set a $12.00 price objective on the stock in a report on Tuesday, September 24th. ...

Who is Mesoblast limited?

(Get Free Report) Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. ...

Does Jane Street Group LLC own Mesoblast?

Jane Street Group LLC boosted its position in Mesoblast by 46.4% during the third quarter. Jane Street Group LLC now owns 85,102 shares of the company’s stock worth $695,000 after purchasing an additional 26,959 shares during the period. Marshall Wace LLP bought a new stake in shares of Mesoblast during the 2nd quarter worth $562,000. ...